Notch Therapeutics
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- $85M
Investors
- 7
About Notch Therapeutics
Founded in 2018 and based in Toronto, Canada, Notch Therapeutics, Inc. operates as a biotechnology company that develops immunotherapy drugs. The company was founded by Sunnybrook Research Institute and the University of Toronto. In February 2021, Notch Therapeutics, Inc., EcoR1 Capital, Casdin Capital, Samsara BioCapital, and Amplitude Ventures. The company develops a pipeline of cellular immunotherapies intended to generate T cells and other immune cells from the clonal stem. The company produces stem cell-derived, gene-edited immune cell therapies and the differentiation of induced pluripotent stem cells without the use of any animal components. The company's revenue is generated from developing immunotherapy drugs in the field of cancer. Notch Therapeutics, Inc. plans to continue the development of Notch's portfolio. The company also plans to expand its team.
Who invested in Notch Therapeutics
7 investors across 1 round
See all investors in Notch Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 10, 2021
Amount
$85M
Investors
Questions about Notch Therapeutics
Who invested in Notch Therapeutics?
Notch Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Notch Therapeutics raised?
Notch Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Notch Therapeutics last raise money?
Notch Therapeutics's most recent round on record is a Series A, in Feb 2021.
What does Notch Therapeutics do?
Founded in 2018 and based in Toronto, Canada, Notch Therapeutics, Inc.
Where is Notch Therapeutics headquartered?
Notch Therapeutics is headquartered in Toronto, Canada.
Which VCs invest in companies like Notch Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Notch Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Notch Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.